aGvHD is a major cause of morbidity and mortality following allogeneic hematopoietic stem cell transplantation. The patients (N=173) treated in EAP previously failed 1 to 6 aGvHD systemic treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback